摘要
炎症被认为在动脉粥样硬化(atherosclerosis,AS)的发生和发展中扮演着关键角色。AS的抗炎治疗已经成为一种具有前景的治疗策略。本文详细探讨了AS与炎症及相关信号通路的关系,介绍了当前针对AS的抗炎治疗策略和未来的研究方向,为深入研究AS抗炎治疗提供参考。
Inflammation is believed to play a pivotal role in the onset and progression of atherosclerosis(AS).Anti-inflammatory treatments for AS have emerged as a promising therapeutic strategy.This article delves into the relationship between AS and inflammatory,as well as associated signaling pathways.It also presents current anti-inflammatory treatment strategies for AS and directions for future research,serving as a reference for in-depth studies on anti-inflammatory treatments for atherosclerosis.
作者
张文鸿
崔璟
刘嘉敏
张燕
洪志博
张宁坤
陈宇
ZHANG Wenhong;CUI Jing;LIU Jiamin;ZHANG Yan;HONG Zhibo;ZHANG Ningkun;CHEN Yu(Department of Cardiology,The Sixth Medical Center of Chinese People's Liberation,Army General Hospital,Beijing,100048,China;Navy Clinical College,The Fifth School of Clinical Medicine,Anhui Medical University)
出处
《临床心血管病杂志》
CAS
2024年第10期845-852,共8页
Journal of Clinical Cardiology
基金
国家重点研发计划(No:2022YFA1104300)
北京市自然科学基金项目(No:7222183)
安徽省研究生质量工程项目(No:2022xscx054)。
关键词
动脉粥样硬化
炎症
信号通路
生物标志物
抗炎治疗
atherosclerosis
inflammation
signaling pathways
biomarkers
anti-inflammatory therapy